Late detection
Most pathways act only after haemoglobin has already dropped.
Sawazisha MedTech Labs · Kigali
ZAWADI™
Blood-free early detection.Before anaemia begins.
Research-stage point-of-care ZPP sensing for women's health — differential photoacoustics at 407 and 425 nm, designed for 30–60 seconds, no needle.
- Method
- 407 / 425 nm
- Mode
- Blood-free
- Signal
- Early ZPP
ZAWADI system
The timing gap
Haemoglobin is a late signal.
ZPP rises while iron stores are still falling — that is the prevention window ZAWADI is built to observe.
Costly workflows
Blood draws and lab loops limit repeat screening at the frontline.
Missed window
Earlier iron restriction is actionable — but rarely visible today.
Product family
Hardware built for the frontline.
Reader, wearable, and single-use pad — one sensing system with clear kit pairing.
Sensing pipeline
Three steps at point of care.
Photoacoustic differential sensing — serious method, frontline-simple workflow.
01 · Interface
Place
Seat the contact pad on skin. No lancet, no blood tube, no biohazard stream.
02 · 407 / 425 nm
Pulse
Fire paired 407 nm and 425 nm optical-acoustic pulses; difference isolates ZPP-related signal.
03 · ≤ 60 sec
Read
Surface a research-prototype ZPP-related estimate designed for under 60 seconds.
Go deeper
Evidence, method, and beachhead.
Short paths into the science deck — no fluff, image-led proof.
Development-stage notice: ZAWADI is under active validation. Not a diagnostic substitute. Regulatory status: Research and development programme — not submitted for regulatory clearance and not offered for clinical diagnosis or commercial use.
Partner with ZAWADI
Pilot, validate, or invest.
Clinical sites, NGOs, and investors — join the calibration and evidence sprint.